Detalhe da pesquisa
1.
Electrophysiological Effects of the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor Dapagliflozin on Human Cardiac Potassium Channels.
Int J Mol Sci
; 25(11)2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38891889
2.
Virus-induced inhibition of cardiac pacemaker channel HCN4 triggers bradycardia in human-induced stem cell system.
Cell Mol Life Sci
; 79(8): 440, 2022 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35864219
3.
Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac Kv4.3 (Ito) Channel Isoforms.
Int J Mol Sci
; 24(18)2023 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762145
4.
Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytes.
Basic Res Cardiol
; 116(1): 13, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33630168
5.
ESC working group on cardiac cellular electrophysiology position paper: relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research.
Europace
; 23(11): 1795-1814, 2021 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34313298
6.
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.
Europace
; 23(3): 329-344, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555020
7.
Electrophysiological effects of non-vitamin K antagonist oral anticoagulants on atrial repolarizing potassium channels.
Europace
; 22(9): 1409-1418, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676673
8.
Cloning and characterization of zebrafish K2P13.1 (THIK-1) two-pore-domain K+ channels.
J Mol Cell Cardiol
; 126: 96-104, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30472253
9.
The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart disease.
Biochem Biophys Res Commun
; 519(1): 141-147, 2019 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31481236
10.
ANK2 functionally interacts with KCNH2 aggravating long QT syndrome in a double mutation carrier.
Biochem Biophys Res Commun
; 512(4): 845-851, 2019 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929919
11.
N-Glycosylation of TREK-1/hK2P2.1 Two-Pore-Domain Potassium (K2P) Channels.
Int J Mol Sci
; 20(20)2019 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31635148
12.
Inhibition of Histone Deacetylases Induces K+ Channel Remodeling and Action Potential Prolongation in HL-1 Atrial Cardiomyocytes.
Cell Physiol Biochem
; 49(1): 65-77, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30134221
13.
New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K2P3.1 (TASK-1) Channels.
J Pharmacol Exp Ther
; 365(3): 614-623, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29643254
14.
Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1.
Basic Res Cardiol
; 113(4): 27, 2018 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29881975
15.
Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.
Heart Vessels
; 33(11): 1390-1402, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29721674
16.
Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry.
Eur Heart J
; 38(17): 1317-1326, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329395
17.
Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.
Eur Heart J
; 38(22): 1764-1774, 2017 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28057773
18.
Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP2-interference.
J Pharmacol Exp Ther
; 361(2): 209-218, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188270
19.
TREK-1 (K2P2.1) K+ channels are suppressed in patients with atrial fibrillation and heart failure and provide therapeutic targets for rhythm control.
Basic Res Cardiol
; 112(1): 8, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28005193
20.
Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.
Circulation
; 132(2): 82-92, 2015 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25951834